Dyfyniad APA

Taylor, P., Keystone, E., Van der Heijde, D., Weinblatt, M., del Carmen Morales, L., Reyes Gonzaga, J., . . . Tanaka, Y. (2017). Baricitinib versus placebo or adalimumab in rheumatoid arthritis. Massachusetts Medical Society.

Dyfyniad Arddull Chicago

Taylor, P., et al. Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis. Massachusetts Medical Society, 2017.

Dyfyniad MLA

Taylor, P., et al. Baricitinib Versus Placebo or Adalimumab in Rheumatoid Arthritis. Massachusetts Medical Society, 2017.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.